Syntenin inhibition impairs stroma‐tumor communication in multiple myeloma and improves bortezomib treatment efficiency
Chenggong Tu(Vrije Universiteit Brussel), Eline Menu(Vrije Universiteit Brussel)
Cited by 2
Related Papers
The bone marrow microenvironment enhances multiple myeloma progression by exosome-mediated activation of myeloid-derived suppressor cells
|Oncotarget|2015|147
Pyrroline-5-Carboxylate Reductase 1: a novel target for sensitizing multiple myeloma cells to bortezomib by inhibition of PRAS40-mediated protein synthesis
|Journal of Experimental & Clinical Cancer Research|2022|31
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis
|The Journal of Pathology|2023|28